Uterine leiomyomata, or fibroids, are the most common pelvic tumors in females and occur in 20-25% of women of reproductive age. Although benign neoplasms, they constitute a major health problem as 25-50% of affected women experience debilitating symptoms including excessive menstrual bleeding and pelvic discomfort as well as reproductive failure. Fibroids are the major indication for hysterectomy accounting for over 200,000 procedures annually in the United States. Although uterine leiomyomata are three to nine times more frequent in Black than Caucasian women, little is known about this racial predisposition or specific genes involved in their pathogenesis. The major goal of this proposed project is to use contemporary techniques of cytogenetics and molecular biology to identify, isolate and characterize genes involved in the pathogenesis of uterine leiomyomata. A positional cloning approach will be taken by microdissection cloning regions of chromosomes known to be consistently involved in rearrangements in these tumors. Identification and molecular characterization of genes at these sites will contribute to understanding the role of these genes in normal cellular processes and, may facilitate developments in the clinical management of leiomyomata and other solid tumors. Proposed experimental design and methods are: (1) to establish and karyotype cell lines from uterine leiomyoma and matched myometrial specimens, (2) to generate a high density of genomic clones from regions involved in chromosome rearrangements in leiomyomata, (3) to identify genomic clones which span or reside within the chromosomal region of interest, (4) to identify candidate genes within these clones, (5) to assess expression of these genes in normal and neoplastic tissues, and (6) to characterize protein products of the genes.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD030498-04
Application #
2202831
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1992-09-30
Project End
1997-08-31
Budget Start
1995-09-01
Budget End
1996-08-31
Support Year
4
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Pedeutour, F; Quade, B J; Sornberger, K et al. (2000) Dysregulation of HMGIC in a uterine lipoleiomyoma with a complex rearrangement including chromosomes 7, 12, and 14. Genes Chromosomes Cancer 27:209-15
Pedeutour, F; Quade, B J; Weremowicz, S et al. (1998) Localization and expression of the human estrogen receptor beta gene in uterine leiomyomata. Genes Chromosomes Cancer 23:361-6
Quintana, D G; Thome, K C; Hou, Z H et al. (1998) ORC5L, a new member of the human origin recognition complex, is deleted in uterine leiomyomas and malignant myeloid diseases. J Biol Chem 273:27137-45
Rein, M S; Powell, W L; Walters, F C et al. (1998) Cytogenetic abnormalities in uterine myomas are associated with myoma size. Mol Hum Reprod 4:83-6
Xing, Y P; Powell, W L; Morton, C C (1997) The del(7q) subgroup in uterine leiomyomata: genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata. Cancer Genet Cytogenet 98:69-74
Quade, B J; McLachlin, C M; Soto-Wright, V et al. (1997) Disseminated peritoneal leiomyomatosis. Clonality analysis by X chromosome inactivation and cytogenetics of a clinically benign smooth muscle proliferation. Am J Pathol 150:2153-66
Schoenberg Fejzo, M; Ashar, H R; Krauter, K S et al. (1996) Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas. Genes Chromosomes Cancer 17:1-6
Fejzo, M S; Yoon, S J; Montgomery, K T et al. (1995) Identification of a YAC spanning the translocation breakpoints in uterine leiomyomata, pulmonary chondroid hamartoma, and lipoma: physical mapping of the 12q14-q15 breakpoint region in uterine leiomyomata. Genomics 26:265-71
Ashar, H R; Fejzo, M S; Tkachenko, A et al. (1995) Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82:57-65
Sargent, M S; Weremowicz, S; Rein, M S et al. (1994) Translocations in 7q22 define a critical region in uterine leiomyomata. Cancer Genet Cytogenet 77:65-8

Showing the most recent 10 out of 11 publications